港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

華芢生物-B

21.980

+0.0800.37%

成交量：20.36萬

成交額：453.65萬

市值：25.86億

市盈率：- -

高：22.880

開：21.900

低：21.900

收：21.900

52周最高：37.200

52周最低：21.820

股本：1.18億

香港流通股本：8,302.21萬

量比：0.12

換手率：0.25%

股息：- -

股息率：- -

淨資產收益率：-2274.80%

總資產收益率：-57.28%

市淨率：27.57

市盈率(LYR):- -

市銷率: 8930.34

資料載入中...

總覽公司新聞資訊公告

華芢生物：PDGF藥物領航，多款核心產品加速推進，孖展估值飆升卻在上市首日破發？

冰與火之歌：寶濟藥業(02589)180%暴漲vs華芢生物(02396)、翰思艾泰(03378)腰斬港股生物科技新股極端分化啓示錄

智通财经网

港股年內4只新股上市首日齊破發

华尔街见闻

「三無」藥企開局遇冷華芢生物上市兩日連挫盈利遙遙無期

深圳商报·读创

上市首日破發近30%，華芢生物-B(02396)「機制B+無基石」難獲市場認可？

異動解讀 | 華芢生物-B盤中大跌5.04%，IPO首日破發後持續承壓

中信證券保薦生物科技領先企業華芢生物登陸港交所

【IPO追蹤】創新藥概念遭遇罕見挫敗，華芢生物上市即破發

40.83億，北京母子倆跑出一個IPO！

动脉新医药

華芢生物今日在港上市青島迎來創新藥第二股

青岛资本圈

異動解讀 | 華芢生物-B(02396)上市首日盤中大跌8.38%，IPO表現不佳及財務擔憂拖累股價

新股首日 | 華芢生物-B(02396)首掛上市早盤低開11.52% 公司為中國領先PDGF藥物生物製藥企業

華芢生物-B以下限定價香港公開發售獲791.95倍認購

一週前瞻｜聯儲局新主席懸念將揭曉！特朗普本週或提前公佈；全球多市場迎聖誕休市

港股公告掘金 | 中國神華擬約1335.98億元向控股股東收購資產並募集配套資金不超過200億元華芢生物、南華期貨股份等4只新股明日上市

華芢生物-B(02396.HK)香港公開發售獲791.95倍認購 12月22日上市

老虎暗盤 | 華芢生物盤初漲逾24%。每手賺超1800港元

老虎资讯综合

新股暗盤 | 華芢生物-B(02396)暗盤盤初漲逾36% 每手賺2760港元

華芢生物的600倍超購熱潮下，是一場情緒狂歡還是價值發現？

Ofweek光电信息网

華芢生物創新藥助力降低醫療負擔，獲資本與市場雙重認可

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02396/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02396","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02396\",,,,,undefined,":{"symbol":"02396","market":"HK","secType":"STK","nameCN":"華芢生物-B","latestPrice":21.98,"timestamp":1766549302746,"preClose":21.9,"halted":0,"volume":203600,"delay":0,"floatShares":83022145,"shares":117657522,"eps":0,"marketStatus":"聖誕節休市","change":0.08,"latestTime":"12-24 12:08:22","open":21.9,"high":22.88,"low":21.9,"amount":4536540,"amplitude":0.044749,"askPrice":22.2,"askSize":400,"bidPrice":21.98,"bidSize":400,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":7,"adr":0,"listingDate":1766332800000,"exchange":"SEHK","adjPreClose":21.9,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":0.123622112435525,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02396\",,,,,undefined,":{"symbol":"02396","floatShares":83022145,"roa":"-57.28%","roe":"-2274.80%","lyrEps":0,"volumeRatio":0.123622112435525,"shares":117657522,"dividePrice":0,"high":22.88,"amplitude":0.044749,"preClose":21.9,"low":21.9,"week52Low":21.82,"pbRate":"27.57","psRate":"8930.34","week52High":37.2,"institutionHeld":0,"latestPrice":21.98,"eps":0,"divideRate":0,"volume":203600,"delay":0,"ttmEps":0,"open":21.9,"prevYearClose":38.2,"prevWeekClose":38.2,"prevMonthClose":38.2,"prevQuarterClose":38.2,"fiveDayClose":38.2,"twentyDayClose":38.2,"sixtyDayClose":38.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02396\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02396\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02396\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02396\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02396","date":"2025-12-24","current":-12.774079,"percent":0.666667,"low":-22.370893,"twenty":-17.071319,"median":-13.156175,"eighty":-12.763931,"high":-12.748708,"avg":-15.357988,"sd":4.061316,"marketCap":2586112333},"quantilePoints":[{"date":"2025-12-19","current":-22.370893,"twenty":-22.370893,"median":-22.370893,"eighty":-22.370893,"marketCap":5247525481},{"date":"2025-12-24","current":-12.774079,"twenty":-17.071319,"median":-13.156175,"eighty":-12.763931,"marketCap":2586112333}],"updateTime":1766632849658},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02396\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2594284506","title":"華芢生物：PDGF藥物領航，多款核心產品加速推進，孖展估值飆升卻在上市首日破發？","url":"https://stock-news.laohu8.com/highlight/detail?id=2594284506","media":"摩熵医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594284506?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 12:13","pubTimestamp":1766635998,"startTime":"0","endTime":"0","summary":"华生物，最早成立于2012年，重点针对有医疗需求及市场机会的适应证开发蛋白质药物。目前公司围绕血小板衍生生长因子药物展开研发。PDGF是损伤后由血小板分泌的一种生长因子，可促进血管新生、调节炎症并刺激细胞增殖与迁移，从而加速伤口愈合。但在12月22日上市第一天，破发。华生物，2021年5月完成Pre-A轮融资，估值8.05亿元；2021年10月完成A轮融资，估值达20.21亿元；2023年5月完成B轮3亿元融资，每股成本为33元，融资估值为33亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225121325a475ede1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225121325a475ede1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02396"],"gpt_icon":1},{"id":"2593942679","title":"冰與火之歌：寶濟藥業(02589)180%暴漲vs華芢生物(02396)、翰思艾泰(03378)腰斬 港股生物科技新股極端分化啓示錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2593942679","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593942679?lang=zh_tw&edition=fundamental","pubTime":"2025-12-24 12:47","pubTimestamp":1766551655,"startTime":"0","endTime":"0","summary":"2025年12月，港股IPO市场上演了一场令人瞠目结舌的“冰与火之歌”。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20251224/20251224125033_33927.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251224/20251224125033_33927.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385346.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02659","02396","BK1233","BK1173","159837","03378","BK1587","BK1535","BK1616","02589"],"gpt_icon":1},{"id":"2593469093","title":"港股年內4只新股上市首日齊破發","url":"https://stock-news.laohu8.com/highlight/detail?id=2593469093","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593469093?lang=zh_tw&edition=fundamental","pubTime":"2025-12-23 13:31","pubTimestamp":1766467875,"startTime":"0","endTime":"0","summary":"12月22日，港股上市的4家公司集体破发。明基医院更是刷新年内港股新股上市首日破发幅度的记录。年内，港股市场一共有31只新股上市首日破发，占当期新股数量的比例为29%左右，较2024年全年下滑了7个百分点。年内31只破发新股中有接近一半均是发生在该季度，这是否会成为2026年港股IPO破发潮的开始，正受到关注。如果拉长时间来看，截至12月22日收盘价，年内共有45只新股跌破发行价，占比超过40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223134413a6c47e63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223134413a6c47e63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02396","02581"],"gpt_icon":0},{"id":"2593669824","title":"「三無」藥企開局遇冷 華芢生物上市兩日連挫 盈利遙遙無期","url":"https://stock-news.laohu8.com/highlight/detail?id=2593669824","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593669824?lang=zh_tw&edition=fundamental","pubTime":"2025-12-23 12:28","pubTimestamp":1766464127,"startTime":"0","endTime":"0","summary":"12月22日，华芢生物科技（青岛）股份有限公司（简称：“华芢生物”，股票代码：“2396”）在港交所上市，开盘价为33.8港元，较发行价下跌11.5%，上市首日即破发。华芢生物发行价为38.2港元，发行17,648,800股，募资总额为6.74亿港元；扣除发行应付上市费用7436万港元，募资净额为6亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233599343879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02396"],"gpt_icon":1},{"id":"2593450055","title":"上市首日破發近30%，華芢生物-B(02396)「機制B+無基石」難獲市場認可？","url":"https://stock-news.laohu8.com/highlight/detail?id=2593450055","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593450055?lang=zh_tw&edition=fundamental","pubTime":"2025-12-23 10:42","pubTimestamp":1766457779,"startTime":"0","endTime":"0","summary":"12月22日，华生物-B正式挂牌上市。下午开盘后，其股价再次持续下跌，最低价跌至31港元，跌幅达21.68%，随着华生物股价午后一路下跌，最终报收27.00港元，跌幅达到29.32%。“机制B+无基石”难获市场认可?其中，华泰国际和中信证券均为华生物此次IPO的保荐人、账簿管理人和承销商。庞大的患者基数，驱动糖尿病药物市场持续扩容。招股书显示，目前华生物的这两个产品正在中国分别针对两个适应症进行II期及IIb期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384771.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"上市首日破发近30%，华芢生物-B(02396)“机制B+无基石”难获市场认可？","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02396"],"gpt_icon":1},{"id":"1131899093","title":"異動解讀 | 華芢生物-B盤中大跌5.04%，IPO首日破發後持續承壓","url":"https://stock-news.laohu8.com/highlight/detail?id=1131899093","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131899093?lang=zh_tw&edition=fundamental","pubTime":"2025-12-23 09:40","pubTimestamp":1766454021,"startTime":"0","endTime":"0","summary":"华芢生物-B(02396)今日盘中大跌5.04%，延续了其上市首日的颓势。消息面上，华芢生物昨日在港交所上市，发行价为38.2港元，但开盘即破发，收盘价较发行价大跌29.32%，显示市场对其前景持谨慎态度。公司目前暂无收入，且一直处于亏损状态，2025年前9个月亏损达1.34亿元，财务状况堪忧。华芢生物是一家创新型生物制药公司，专注于伤口愈合的蛋白质药物开发，但其核心产品尚处于临床试验阶段，商业化前景不明。投资者对其长期盈利能力的担忧可能是导致股价持续下跌的主要原因。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02396"],"gpt_icon":0},{"id":"2593870485","title":"中信證券保薦生物科技領先企業華芢生物登陸港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2593870485","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593870485?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 17:30","pubTimestamp":1766395857,"startTime":"0","endTime":"0","summary":"来源：市场资讯 2025年12月22日，华生物科技（青岛）股份有限公司成功于香港联交所主板上市，发行规模约6.74亿港元。中信证券发挥专业优势助力中国生物科技公司高质量发展中信证券积极践行金融服务国家战略和实体经济，深度布局生物医药产业，充分发挥专业优势，服务生物医药产业链优质企业高质量发展。本项目是中信证券推动服务创新型生物医药行业的又一典型案例。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222173633a6c0dd8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222173633a6c0dd8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1720050803.USD","BK1564","02396","BK1521","LU1794554557.SGD","BK1516","BK1147","06030"],"gpt_icon":0},{"id":"2593010404","title":"【IPO追蹤】創新藥概念遭遇罕見挫敗，華芢生物上市即破發","url":"https://stock-news.laohu8.com/highlight/detail?id=2593010404","media":"IPO解码","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593010404?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 14:49","pubTimestamp":1766386150,"startTime":"0","endTime":"0","summary":"总的来看，华生物在香港公开发售方面的表现不错，认购倍数较高。根据资料，华生物是一家总部位于中国的生物制药公司，致力于开发各类疗法，重点是针对有医疗需求及市场机会的适应症开发蛋白质药物。此外，华生物还有八款其他候选产品。希迪智驾跌14%，一手蚀387港元岁末新股热潮，六股同日招股！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222152356a6c04bb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222152356a6c04bb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","02396","BK1574","BK1161"],"gpt_icon":1},{"id":"2593880170","title":"40.83億，北京母子倆跑出一個IPO！","url":"https://stock-news.laohu8.com/highlight/detail?id=2593880170","media":"动脉新医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593880170?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 10:27","pubTimestamp":1766370433,"startTime":"0","endTime":"0","summary":"本次IPO，华生物开盘价33.8港元，截至上午10点，其总市值约40.83亿港元。2020年，中宏赛思更名为北京华生物技术有限公司。2023年，进一步更名为华生物科技（青岛）有限公司，并同步将注册办公地址从北京变更至青岛。目前，该公司已建有蛋白质╱多肽医药平台以及核酸医药平台。其中，mRNA分子设计技术有助于确保mRNA药物实现高水平表达，并减少潜在副作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222103054a6bf5857&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222103054a6bf5857&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02396","BK1515","BK1161","09939","BK1574"],"gpt_icon":1},{"id":"2593172732","title":"華芢生物今日在港上市 青島迎來創新藥第二股","url":"https://stock-news.laohu8.com/highlight/detail?id=2593172732","media":"青岛资本圈","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593172732?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 09:37","pubTimestamp":1766367464,"startTime":"0","endTime":"0","summary":"12月22日，华生物科技(青岛)股份有限公司在港交所敲钟。华生物成为青岛第86家上市公司，也是今年继泰凯英之后第二家新上市公司，为2025年青岛资本市场工作画上圆满句号。华生物发售价定为38.20港元/股，本次全球发售共发行1764.88万股H股。华生物的核心业务聚焦于 PDGF 药物的研发与商业化。国投证券国际表示，华生物作为中国领先PDGF药物生物制药企业，拥有七款PDGF候选药物。此次成功在港交所上市，标志着华生物即将开启资本市场的新征程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222094457a468215b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222094457a468215b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06978","02396","BK1574"],"gpt_icon":1},{"id":"1135503127","title":"異動解讀 | 華芢生物-B(02396)上市首日盤中大跌8.38%，IPO表現不佳及財務擔憂拖累股價","url":"https://stock-news.laohu8.com/highlight/detail?id=1135503127","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135503127?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 09:33","pubTimestamp":1766367194,"startTime":"0","endTime":"0","summary":"华芢生物-B(02396)今日盘中大跌8.38%，引发市场关注。该股为今日新上市的生物制药公司，开盘即较发行价38.2港元低开11.52%，盘中跌幅进一步扩大。消息面上，华芢生物-B的IPO表现不佳是股价下跌的主要原因。尽管其香港公开发售部分获得了791.95倍的超额认购，但投资者对公司的财务健康状况持谨慎态度。招股书显示，公司2024年及2025年前九个月收入为零，净亏损持续扩大至人民币2.12亿元，且完全依赖融资维持运营。此外，其核心产品仍处于临床研发阶段，尚未产生商业化收入，进一步加剧了市场担忧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02396"],"gpt_icon":0},{"id":"2593794174","title":"新股首日 | 華芢生物-B(02396)首掛上市 早盤低開11.52% 公司為中國領先PDGF藥物生物製藥企業","url":"https://stock-news.laohu8.com/highlight/detail?id=2593794174","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593794174?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 09:21","pubTimestamp":1766366481,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华生物-B首挂上市，公告显示，每股定价38.2港元，共发行1764.88万股股份，每手200股，所得款项净额约6亿港元。截至发稿，跌11.52%，报33.8港元，成交额1.03亿港元。公开资料显示，华生物成立于2012年，是一家总部位于中国的生物制药公司，致力于开发疗法，重点是针对有医疗需求及市场机会的适应症开发蛋白质药物。根据弗若斯特沙利文报告，截至最后实际可行日期，中国有三条PDGF药物管线。截至同日，在中国尚无获批的PDGF药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02396"],"gpt_icon":1},{"id":"2593171256","title":"華芢生物-B以下限定價 香港公開發售獲791.95倍認購","url":"https://stock-news.laohu8.com/highlight/detail?id=2593171256","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593171256?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 08:52","pubTimestamp":1766364720,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　华芢生物-B（02396）公布配发结果，公司全球发售1764.88万股股份，香港公开发售占10%，国际发售占90%。每股发售价38.2港元，净筹约6亿港元。每手200股，预期H股将于2025年12月22日（星期一）上午九时正（香港时间）开始在联交所买卖。\n　　其中，香港公开发售获791.95倍认购，国际发售获6.05倍认购。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2025-12-22/doc-inhcrpzv6542091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02396"],"gpt_icon":0},{"id":"1115145371","title":"一週前瞻｜聯儲局新主席懸念將揭曉！特朗普本週或提前公佈；全球多市場迎聖誕休市","url":"https://stock-news.laohu8.com/highlight/detail?id=1115145371","media":"老虎資訊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115145371?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 07:34","pubTimestamp":1766360099,"startTime":"0","endTime":"0","summary":"12月25日，美股市场全天休市。下任美联储主席遴选进程继续推进下任美联储主席的遴选进程仍在持续。此外，特朗普放话称，下一任美联储主席必须是“超级鸽派”，将很快公布人选。会议决定，十四届全国人大常委会第十九次会议12月22日至27日在北京举行。每股发售价12港元，全球发售净筹约12.03亿港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/a9153adf328cdbdfbb656ed3026a6175","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a9153adf328cdbdfbb656ed3026a6175"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"89e71bac32796c2c1fe565516e5ca133","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"一周前瞻｜美联储新主席悬念将揭晓！特朗普本周或提前公布；全球多市场迎圣诞休市","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".IXIC","07226","07500",".DJI","02691","TLT","02695","02581","YANG","YMmain","QQQ","07200","SPXL","TQQQ","HSI","YINN","SQQQ",".SPX","ESmain","SDOW","CWEB","SOXS","NQmain","HSTECH","SPY","07552","TMF","HSCEI","SOXL","02396"],"gpt_icon":1},{"id":"2593247271","title":"港股公告掘金 | 中國神華擬約1335.98億元向控股股東收購資產並募集配套資金不超過200億元 華芢生物、南華期貨股份等4只新股明日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2593247271","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593247271?lang=zh_tw&edition=fundamental","pubTime":"2025-12-21 20:01","pubTimestamp":1766318500,"startTime":"0","endTime":"0","summary":"【新股上市】南华期货股份(02691)：香港公开发售获1.91倍认购 每股发售价12港元明基医院(02581)：香港公开发售获6.28倍认购 每股发售价9.34港元华生物-B(02396)以下限定价 香港公开发售获791.95倍认购印象大红袍(02695)：香港公开发售获3397.48倍认购 每股发售价3.6港元【重大事项】中国神华(01088)拟约1335.98亿元向控股股东收购资产并募集配套资","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384129.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1251922891.USD","IE0003851619.USD","BK1589","LU0348814723.USD","LU0577902298.EUR","LU0132412106.USD","LU0214875030.USD","LU0819121731.USD","LU1044874839.SGD","LU0169518387.USD","LU1642822792.SGD","LU2237443549.SGD","BK1586","LU1804176565.USD","SG9999001093.SGD","LU0823413587.USD","LU0070217475.USD","LU0359202008.SGD","SG9999018857.SGD","LU0449515922.USD","BK1095","LU2317271919.USD","CSUAY","BK0188","IE00B031J352.USD","SG9999001069.SGD","BK1591","LU2251237306.USD","LU1226288253.USD","LU0211331839.USD","LU1961090484.USD","SG9999015952.SGD","LU0348816934.USD","LU0865486749.SGD","LU0072913022.USD","LU0577902538.SGD","SG9999014674.SGD","IE00B0JY6N72.USD","LU0054237671.USD","LU1725190679.HKD","LU0149721374.USD","LU0469268626.HKD","LU1323998911.USD","LU0181495838.USD","LU2177674079.SGD","BK1517","LU1974910355.USD","SGXZ31699556.SGD","LU0608807946.USD","LU0572939691.SGD","LU0293314216.USD","BK0015","LU0821914370.USD","LU2226246903.HKD","BK1516","LU0048388663.USD","LU0254981946.USD","LU1051769294.HKD","LU0878004406.USD","IE0003895053.USD","LU0228367735.SGD","LU2237443465.HKD","SG9999002463.SGD","LU1226287792.SGD","IE00B0169L03.USD","LU0588546209.SGD","LU0499858438.USD","LU2097828557.USD","IE0032834883.USD","LU0502904849.HKD","LU0541501648.USD","IE00BF5LJ272.USD","LU0823041008.USD","LU0320764243.SGD","BK0266","LU0188438112.USD","HK0000306701.USD","LU0828238088.HKD","LU1981816686.USD","LU0856984785.SGD","LU2449936058.SGD","LU0683595622.HKD","LU0431992006.USD","LU0348783662.USD","LU0106959298.USD","LU2279701549.SGD","LU0067412154.USD","LU0784639295.USD","LU2237443978.SGD","LU0828237510.HKD","LU0084288322.USD","IE0001KFT4U8.USD","LU0096374516.USD","LU0149534421.HKD","LU1813983027.USD","LU0531970944.HKD","LU0441854154.USD","LU0589944569.HKD","SG9999000327.SGD","IE00B8L5B284.USD","LU1831875114.USD","LU1044876610.USD","SG9999014880.SGD","SG9999014898.SGD","LU0672654166.SGD","LU1993786604.SGD","LU2152927971.USD","02396","LU1720050803.USD","LU0651946864.USD","IE0032431581.USD","LU0314109678.HKD","SG9999000459.SGD","LU0320764755.SGD","LU0823040885.USD","LU0315178854.USD","LU0128522157.USD","IE00B8HQ1Z84.USD","GB00BDT5M118.USD","LU0173614495.USD","LU1048484197.HKD","LU2251237488.HKD","BK1191","LU2399975544.HKD","LU0708995153.HKD","LU0823038988.USD","LU0985320562.USD","LU0345769631.USD","LU1568876335.HKD","LU0143863198.USD","LU2362541513.USD","LU1196710351.USD","IE0008368742.USD","IE00B97KM107.HKD","BK1531","IE00B0169N27.USD","LU1868837565.USD","BK0196","BK1538","LU0048597586.USD","IE00BZ08YT58.USD","LU0577902371.SGD","LU0289960550.SGD","LU1769817179.HKD","LU0979878070.USD","LU0642271901.SGD","BK1609","IE0008368411.USD","LU0047713382.USD","LU0516422952.EUR","LU0264606111.USD","LU1481107354.HKD","IE0009570106.USD","LU0737861699.HKD","BK1594","LU0029875118.USD","IE00B29SXG58.USD","LU1226288097.SGD","LU0918141887.USD","LU1568876251.USD","LU0307460666.USD","HK0000320264.USD","LU2106854487.HKD","BK0012","LU0164880469.USD","LU0061477393.USD","LU0106259558.USD","LU0164872284.USD","LU0117841782.USD","BK0179","LU0516422366.SGD","SG9999014906.USD","LU0456842615.SGD","SG9999014914.USD","LU0348723411.USD","BK0006","LU0823039010.USD","LU0417516738.SGD","LU0229945570.USD","LU0348825331.USD","LU0898667661.SGD","LU0509642566.USD","SG9999007991.SGD","LU0029874905.USD","LU1769817096.USD","LU0417516902.SGD","LU0163747925.USD","LU1655091459.SGD","LU0449509016.USD","LU0456827905.SGD","LU0607220059.USD","BK1615","LU0345776255.USD","LU1868838027.USD","LU0611395673.USD","LU0823413660.USD","LU0164865239.USD","LU0456846285.SGD","LU0052750758.USD","LU2265009873.SGD","LU0634319403.HKD","LU1794554557.SGD","IE00B3M56506.USD","LU0572944931.SGD","LU1226287875.USD","IE00B067MR52.USD","LU1328615791.USD","LU0791591158.USD","LU0231483743.USD","LU2247934214.USD","LU1188198961.HKD","LU1196710864.SGD","SG9999000418.SGD","LU1303224171.USD","LU0791590937.USD","LU0873338254.USD","SG9999001051.SGD","LU0235996351.USD","LU0072462343.USD","LU1242518857.USD","BK1505","SG9999013353.USD","LU0417516571.SGD","IE00B031HW06.USD","LU0588545730.USD","LU0593848301.USD","SGXZ90724238.SGD","LU0823397103.USD","LU1023057109.AUD","SG9999001846.SGD","LU0261947096.USD","LU2257852520.SGD","LU0192582467.USD","LU2237443382.USD","LU0143863784.USD","BK1502","IE0031814852.USD","LU0348735423.USD","LU1211504680.USD","LU0823397285.USD","LU0823426480.USD","LU0048580855.USD","LU1629966141.USD","BK1178","LU1810669033.SGD","IE00BQXX3C00.GBP","LU1282649067.USD","LU0633140727.USD","IE00BGV7N243.SGD","LU0882747503.HKD","LU1808992512.USD","IE00BPRC5H50.USD","LU1328277881.USD","LU1226287529.USD","LU0348784397.USD","LU1051768304.USD","LU1785774172.SGD","SG9999015978.USD","LU0543330566.HKD","LU0868486357.SGD","LU1770034418.SGD","LU2097828631.EUR","LU1044875133.USD","LU1196710195.USD","LU1226288170.HKD","LU0396098781.USD","LU1008478684.HKD","LU0594300419.USD","SG9999006514.SGD","LU0463099449.HKD","02691","LU2008162690.USD","LU0049112450.USD","LU0823426308.USD","LU0320764599.SGD","BK1151","LU0516423091.SGD","LU0165289439.USD","LU0455707207.USD","LU0128522744.USD","LU0211977185.USD","HK0000320223.HKD","LU1102505929.USD","SG9999003461.SGD","LU0384037296.USD","LU2237443622.USD","LU1880383440.USD","BK1173","SGXZ51526630.SGD","LU1102505762.USD","LU0370786039.SGD","LU0287142896.SGD","LU0051755006.USD","LU2087589342.USD","LU0831103253.SGD","LU0210527791.USD","LU1504937902.USD","IE0003795394.USD","BK0010","LU0577902454.USD","LU0700851271.USD","LU0348805143.USD","BK0187","LU0269904917.USD","LU2133065610.SGD","BK1521","BK0028","LU1733274473.HKD","LU0203347892.USD","LU1439102457.SGD","TCHmain","LU1675838814.USD","SG9999002562.SGD","LU0650527681.SGD","LU0605514214.HKD","LU1951186391.HKD","LU0588545490.SGD","LU0878005551.USD","LU0633140560.USD","LU0540923850.HKD","LU1282648689.USD","LU0516422440.USD","LU2778985437.USD","IE0008369823.USD","LU0608807433.USD","601088","BK1610","LU2023250504.SGD","LU0244354667.USD","LU2125910849.SGD","LU2097828474.EUR","LU0531971595.HKD","LU0011963245.USD","LU1105468828.SGD","LU1734074674.USD","LU1883866441.USD","SG9999018865.SGD","LU0210533765.USD","LU0871576103.HKD","LU2362540622.SGD","LU1224709979.USD","LU0196878994.USD","LU1814569148.SGD","LU0326950275.SGD","SG9999001689.USD","SG9999002950.SGD","LU2125910500.SGD","LU1048588211.SGD","LU0819123356.HKD","LU2293587155.HKD","LU1917777945.USD","LU0651947912.USD","LU0259732245.USD","01088","LU0175139822.USD","LU0345769128.USD","LU1242518931.SGD","LU0862451753.SGD","LU2051468812.USD","BK1608","LU0328353924.USD","LU0359201885.HKD","LU0414403682.SGD","IE00BZ08YR35.GBP","LU0862451837.USD","LU1366334578.USD","IE0034224299.USD","LU0488056044.USD","LU2362541273.HKD","SG9999001903.USD","IE00B031HY20.USD","LU0043850808.USD","LU2498475776.HKD","LU2213484517.USD","IE00B543WZ88.USD","LU2039709279.SGD","LU0107464264.USD","LU0648948544.HKD","LU0261950983.USD","SG9999017495.SGD","LU1366334651.USD","LU1515016050.SGD","LU0326948709.USD","LU0594300179.USD","LU0541502299.USD","LU0572940350.SGD","LU1282649141.HKD","LU0117844026.USD","LU0106252389.USD","LU0588545904.SGD","LU0228659784.USD","LU1807302812.USD","SG9999015986.USD","SG9999004220.SGD","LU1960683339.HKD","LU0737861772.HKD","LU1880383366.USD","LU0329678170.USD","LU1718418525.SGD","LU0501845795.SGD","LU1868837722.USD","IE00BQXX3D17.EUR","LU2237443895.HKD","LU0054450605.USD","LU0359201612.USD","LU1046422090.SGD","LU0203345920.USD","LU0348788117.USD","LU1770036033.HKD","LU1439103000.SGD","SGXZ99366536.SGD","SG9999015945.SGD","LU0738912210.USD","LU0210526637.USD","LU2476274720.SGD","SG9999001226.SGD","LU0345775950.USD","LU0561508036.HKD","LU0880133367.SGD","LU1224444064.USD","LU1152091168.USD","LU0577902611.USD","IE00B5MMRT66.SGD","LU2045819591.USD","LU0140636845.USD","LU1282651121.HKD","LU1733274390.USD","LU0543330483.HKD","LU0890818403.SGD","LU0251144936.SGD","LU2097828805.USD","LU0049853897.USD","HTCD.SI","LU0348783233.USD","LU0797268264.HKD","LU1316542783.SGD","BK1526","LU0127658192.USD","LU0886674414.USD","LU0918141705.HKD","LU3063872942.SGD","HK0000306685.HKD","LU0080751232.USD","LU1282649810.SGD","LU2242644610.SGD","LU2097828714.EUR","LU2462611646.USD","LU0327786744.USD","LU1282651048.USD","LU0499858602.USD","BK1618","LU2476274308.USD","LU0516423174.USD","LU0039217434.USD","SG9999002828.SGD","LU0348827113.USD","LU1152091754.HKD","SGXZ81514606.USD","LU0972618739.USD","LU1048596156.SGD","LU0675040207.SGD","LU0329678337.USD","LU0708995583.HKD","IE00BQXX3F31.USD","LU0828237940.HKD","LU1688375341.USD","LU1719994722.HKD","SG9999006597.SGD","LU0786609619.USD","IE00BZ08YS42.EUR","LU1235295612.USD","LU1956131251.USD"],"gpt_icon":1},{"id":"2592435167","title":"華芢生物-B(02396.HK)香港公開發售獲791.95倍認購 12月22日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2592435167","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592435167?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 21:37","pubTimestamp":1766151422,"startTime":"0","endTime":"0","summary":"格隆汇12月19日丨华芢生物-B(02396.HK)公告，公司全球发售17,648,800股H股，每股H股38.20港元，所得款项净额6亿港元。香港公开发售股份数目占全球发售股份数目10.00%，获认购791.95倍；国际发售股份数目占全球发售股份90.00%，获认购倍6.05倍。\r\n\r\n　　假设全球发售于2025年12月22日(星期一)上午八时正或之前(香港时间)成为无条件，预期H股将于2025年12月22日(星期一)上午九时正(香港时间)开始在联交所买卖。H股将以200股H股为一手买卖单位进行交易，H股的股份代号为2396。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"295bb8250a496f337a8f98be7a6677c9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251219/31878824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02396"],"gpt_icon":0},{"id":"1138414593","title":"老虎暗盤 | 華芢生物盤初漲逾24%。每手賺超1800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138414593","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138414593?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 16:23","pubTimestamp":1766132635,"startTime":"0","endTime":"0","summary":"是一家总部位于中国的生物制药公司。","market":"hk","thumbnail":"https://static.tigerbbs.com/6f777cdec095188a4671e8bce7ee12d0","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6f777cdec095188a4671e8bce7ee12d0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"gpt_icon":0},{"id":"2592154355","title":"新股暗盤 | 華芢生物-B(02396)暗盤盤初漲逾36% 每手賺2760港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592154355","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592154355?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 16:16","pubTimestamp":1766132161,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华芢生物-B(02396)将于12月22日(周一)在香港挂牌。截至发稿，暗盘交易显示报价52.0港元，较招股价38.20港元上涨36.13%，每手200股，不计手续费，每手赚2760港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"295bb8250a496f337a8f98be7a6677c9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383648.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02396"],"gpt_icon":0},{"id":"2592776849","title":"華芢生物的600倍超購熱潮下，是一場情緒狂歡還是價值發現？","url":"https://stock-news.laohu8.com/highlight/detail?id=2592776849","media":"Ofweek光电信息网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592776849?lang=zh_tw&edition=fundamental","pubTime":"2025-12-18 18:09","pubTimestamp":1766052540,"startTime":"0","endTime":"0","summary":"情绪先于基本面，谁在把华生物推向600倍超购？华生物的第一重吸引力，来自PDGF在中国市场处于空白市场。此次华生物的超额认购，很大程度上由孖展资金驱动。换句话说，华生物的火爆，更像是一场由资金结构、板块情绪与稀缺叙事共同催化的资本事件，而不是一次已经被基本面充分验证的价值发现。华生物在招股书中提到，计划在未来六年内独立实现至少两款创新药的商业化，这本身就是一个对执行力、资金耐力与市场能力要求较高的目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218182003a45b1655&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218182003a45b1655&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02396"],"gpt_icon":0},{"id":"2592697289","title":"華芢生物創新藥助力降低醫療負擔，獲資本與市場雙重認可","url":"https://stock-news.laohu8.com/highlight/detail?id=2592697289","media":"极目新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592697289?lang=zh_tw&edition=fundamental","pubTime":"2025-12-18 18:04","pubTimestamp":1766052252,"startTime":"0","endTime":"0","summary":"同时公司港股上市进入新阶段，开启技术产业化与市场扩张的双重征程。华生物攻克技术瓶颈后，使该候选药活性较全球同类获批药物提升75倍，在安全性与有效性上构建核心竞争力。在研发布局上，华生物已构建起覆盖多种创面适应症的丰富管线，其中7款PDGF系列药物形成鲜明技术特色与产品矩阵，为持续发展奠定基础。值得一提的是，华生物的创新实践兼具产业价值与社会担当。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218180736a45b0a13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218180736a45b0a13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02396","06978","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}]}}